Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Olmesartan, Losartan, and Atenolol on Insulin Sensitivity
NCT00185094Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Feb 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olmesartan in hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd.. Started Feb 2004; status: completed.
02
Drugs
olmesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00185094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185094.